Table 1.

‘Success rates’ (percentage of patients with reductions in PASI and SAPASI scores of ≥75%) and changes in baseline PASI and SAPASI scores and skin hydration following treatment of psoriatic lesions with BMVP or BMV cream 0.12%.29

Outcome	BMVP	Betamethasone valerate cream 0.12%
PASI
Change in baseline score	−10.2 (−61.8%)*,**	−6.3 (−38.4%)*
75% success rate	38.1%	11.9%
SAPASI
Change in baseline score	−11.5 (−59.3%)*,**	−6.6 (−34%)*
75% success rate	26.2%§	9.5%
Skin hydration
Change in baseline score	+7 (+38.8%)**	+1.98 (+11.1%)

^*Statistically significant versus baseline (p<0.001);

^**statistically significant versus cream (p<0.001);

^§statistically significant versus cream (p<0.05).

BMVP, betamethasone valerate medicated plaster; PASI, psoriasis area and severity index; SAPASI, self-administered PASI.